DJIA 17,678.70 6.10 0.03%
NASDAQ 4,771.76 13.88 0.29%
S&P 500 2,057.09 5.27 0.26%
market minute promo

Cepheid (NASDAQ: CPHD)

54.53 -0.49 (-0.89%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CPHD $54.53 -0.89%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $54.95
Previous Close $55.02
Daily Range $54.12 - $55.31
52-Week Range $36.94 - $57.47
Market Cap $3.8B
P/E Ratio -101.89
Dividend (Yield) $0.00 (0.0%)
Volume 686,684
Average Daily Volume 507,077
Current FY EPS -$0.52

Sector

Technology

Industry

Electronics

Cepheid (CPHD) Description

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets. Website: http://www.cepheid.com/

News & Commentary Rss Feed

Why Cepheid Stock Nosedived

Molecular diagnostic company Cepheid may need to do some internal analyzing after its full-year outlook failed to excite investors.

Analyst’s 8 Top Health Care Stocks for 2015

Interesting CPHD Call Options For February 20th

Cepheid's (CPHD) Xpert HIV Test Wins CE-IVD Mark in Europe - Analyst Blog

Benzinga's Top Upgrades

Top Analyst Upgrades and Downgrades: AMD, Ally, FedEx, Halliburton, Intel, Tenet, Tyco and More

First Week of CPHD June 2015 Options Trading

UPDATE: Citigroup Reiterates On Cepheid Following Positive Data

Cepheid Wins FDA Clearance for Xpert Norovirus Test - Analyst Blog

Cepheid Wins FDA Clearance for Xpert Norovirus Test - Analyst Blog

Cepheid Receives FDA Clearance For Xpert Norovirus, The First On-Demand Molecular Test For Detection

Cepheid Receives FDA Clearance For Xpert Norovirus, The First On-Demand Molecular Test For Detection of Norovirus

Cepheid Gets FDA Clearance for Xpert Flu/RSV XC Test - Analyst Blog

See More CPHD News...

CPHD's Top Competitors

CPHD $54.53 (-0.89%)
Current stock: CPHD
AMGN $159.73 (-0.05%)
Current stock: AMGN
GILD $107.12 (1.50%)
Current stock: GILD
BIIB $362.44 (1.37%)
Current stock: BIIB